Recently, delegates from the 2012 meeting of the American Medical Association (AMA) voiced opposition to state and national legislation to allow pharmacists the authority to prescribe medications without a valid prescription.  Read more about the FDA proposal here and here.  The recent response from the ADA can be found here.

Should pharmacists advocate to expand the scope of OTC drugs, or do barriers to the FDA proposal present too great a challenge for implementation?